A panel advising the US Food and Drug Administration (FDA) is meeting to debate the need for additional doses of the Moderna and Johnson & Johnson vaccines.
A panel advising the US Food and Drug Administration (FDA) is meeting to debate the need for additional doses of the Moderna and Johnson & Johnson vaccines.